[Skip to Navigation]
Sign In
Viewpoint
August 22/29, 2017

Multidimensional Evidence Generation and FDA Regulatory Decision Making: Defining and Using “Real-World” Data

Author Affiliations
  • 1Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland
JAMA. 2017;318(8):703-704. doi:10.1001/jama.2017.9991
Add or change institution
×